Gillian Ellison

Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer

Fred R. Hirsch, Marileila Varella‐Garcia, Paul A. Bunn et al. · Journal of Clinical Oncology · 2006 · 702 citations · Full text

Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)

Jonathan R. Dry, Sandra Pavey, Christine A. Pratilas et al. · Cancer Research · 2010 · 261 citations · Full text

Cell Subsets, Tumor Biology, Transcriptional Regulation +17

Further evidence to support the melanocytic origin of MDA-MB-435

Gillian Ellison · Molecular Pathology · 2002 · 165 citations · Full text

A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples

Gillian Ellison, Emma Donald, Gael McWalter et al. · Journal of Experimental & Clinical Cancer Research · 2010 · 152 citations · Full text

The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies

Xiaoqing Liu, Yachao Lu, Guanshan Zhu et al. · Journal of Clinical Pathology · 2013 · 148 citations · Full text